Application 213665

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FLUCYTOSINEFLUCYTOSINECAPSULE;ORAL250MGNoNo
002FLUCYTOSINEFLUCYTOSINECAPSULE;ORAL500MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59651-331FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-331FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-331FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-331FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-332FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-332FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-332FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
59651-332FLUCYTOSINEFLUCYTOSINEAurobindo Pharma LimitedANDACurrent
60687-599FLUCYTOSINEFLUCYTOSINEAmerican Health PackagingANDACurrent
60687-599FlucytosineFlucytosineAmerican Health PackagingANDACurrent
60687-610FLUCYTOSINEFLUCYTOSINEAmerican Health PackagingANDACurrent
60687-610FlucytosineFlucytosineAmerican Health PackagingANDACurrent